The current paradigm in macrophage biology is that some tissues mainly contain macrophages from embryonic origin, such as microglia in the brain, whereas other tissues contain postnatalderived macrophages, such as the gut. However, in the lung and in other organs, such as the skin, there are both embryonic and postnatal-derived macrophages. In this study, we demonstrate in the steady-state lung that the mononuclear phagocyte system is comprised of three newly identified interstitial macrophages (IMs), alveolar macrophages, dendritic cells, and few extravascular monocytes. We focused on similarities and differences between the three IM subtypes, specifically, their phenotype, location, transcriptional signature, phagocytic capacity, turnover, and lack of survival dependency on fractalkine receptor, CX 3 CR1. Pulmonary IMs were located in the bronchial interstitium but not the alveolar interstitium. At the transcriptional level, all three IMs displayed a macrophage signature and phenotype. All IMs expressed MER protooncogene, tyrosine kinase, CD64, CD11b, and CX 3 CR1, and were further distinguished by differences in cell surface protein expression of CD206, Lyve-1, CD11c, CCR2, and MHC class II, along with the absence of Ly6C, Ly6G, and Siglec F. Most intriguingly, in addition to the lung, similar phenotypic populations of IMs were observed in other nonlymphoid organs, perhaps highlighting conserved functions throughout the body. These findings promote future research to track four distinct pulmonary macrophages and decipher the division of labor that exists between them.
The naive, nonstimulated lung contains a number of different types of resident mononuclear phagocytes. These include monocytes, dendritic cells (DCs), and macrophages. Resident alveolar macrophages (AMs) present in the alveolar air space have been extensively studied, are now known to arise during embryogenesis, and are ontologically distinct from cells derived from postnatal hematologic origin (1) (2) (3) . Earlier studies of the so-called "marginating" pool of pulmonary leukocytes emphasized that a substantial proportion of circulating monocytes at any point in time reside within the pulmonary microvasculature. In addition, it has been shown in the naive animal that the lung contains another population of macrophages, distinct from AMs, monocytes, and DCs (4, 5) : the interstitial macrophages (IMs). These IMs have not been well characterized, in part because of difficulties in identification and isolation. Moreover, their precise location within the lung has been controversial.
The innate immune system is increasingly recognized as a crucial contributor to tissue homeostasis, both for the recognition and removal of external or endogenous insults as well as for the maintenance of normal tissue structure and function. This is especially relevant in the lung, due to its continuous and extensive exposure to the environment. The lack of defined information about the nature and location of the pulmonary IMs provided the stimulus for this study, in which we characterized their phenotype and turnover at baseline in the "normal" lung to thereby set the stage for understanding their roles in health and disease. Here, new techniques for identification, isolation, and characterization of IMs in normal, young-adult, C57BL/6 mice were employed, and have resulted in the description of three separable and substantially self-renewing populations of macrophages. These IMs exhibited different transcriptomal profiles, and were shown to be located in the interstitium of the bronchovascular bundles, but not in the alveolar walls. Notably, preliminary comparison with other tissues also showed three similar populations of IMs to be present in heart, gut, and skin.
Materials and Methods

Mice
Cluster of differentiation (CD) 45.1 and CD45.2 C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor, ME) and Charles River Laboratories (Worcester, MA). CCR2 (4Get) mice were acquired from Dr. Philippa Marrack (Denver, CO). Mice were used at 6-10 weeks of age, housed in a specific pathogen-free environment at National Jewish Health (Denver, CO), and used in accordance with protocols approved by the Institutional Animal Care and Use Committee.
Bone Marrow Chimeras
Protection of lung macrophages during irradiation was performed as previously described (6) . CD45.1 recipient wild-type mice were anesthetized with Avertin using 300 ml per mouse with tert-amyl alcohol content at 2.5% and 2,2,2 tribromoethanol (T1420; TCI America, Portland, OR) at a concentration of 50 mg/kg, and positioned between lead strips 1-cm thick by 2-cm wide to protect the lungs from radiation. g radiation (900 Gy) from a cesium-131 source was used. CD45.2 bone marrow (BM) cells were prepared by flushing donor femurs and tibias with PBS. Cells were counted and transferred into recipient mice after radiation exposure. Chimeric mice were used for studies at 5 weeks after radiation and BM transfer.
Parabiosis
Parabiotic mice were created using a previously published protocol (7) . Briefly, mice were continuously anesthetized with isofluorane and kept on a heated pad throughout surgery. Animal partners were shaved on opposing sides followed by an incision from the elbow to the knee. First, joints of the elbows and knees were sutured together using 3-0 nonabsorbable sutures. Then, dorsal-dorsal and ventral-ventral skin was joined using an absorbable 5-0 Vicryl suture. Finally, mice were administered carprofen for pain relief, as needed, and were kept on antibiotic Septra diet to prevent postoperative infections.
Preparation of Single-Cell Suspensions from Organs
Blood was drawn by cardiac puncture using a 26-gauge syringe coated with 100 mM EDTA to prevent coagulation, followed by lysis with BD Pharm lyse (BD Biosciences, San Jose, CA) red blood cell lysis buffer. Bronchoalveolar lavage was obtained by flushing the airways four times with 1 ml of cold PBS only. Mice were perfused via the heart with 20 ml of PBS. Lung and heart tissues were finely minced with scissors before digestion. The dorsal and ventral sides of the ears were separated before floating dermis-side down on digestion solution. Lungs and ear skin were digested with 500 mg/ml Liberase (Roche/Sigma, Branford, CT/St. Louis, MO). The heart was digested using collagenase D (Roche/Sigma) at 2.5 mg/ml for 30 minutes at 37 8 C. Single-cell suspensions were obtained by repeated glass pipetting before cells were filtered through a 100-mm nylon filter. Colon samples were prepared by first flushing and incubating gut tissue with buffer containing EDTA to deplete gut epithelial cells. The remaining colon tissue was minced and digested with a mixture of 0.85 mg/ml collagenase VIII and 1.2 mg/ml collagenase D (Roche, Branford, CT) to obtain single-cell suspensions. In some instances, cells of interest were enriched by MACS bead purification (Miltenyi, San Diego, CA) using either anti-CD11c and anti-CD11b microbeads, or biotinylated anti-MerTK using anti-biotin microbeads before analysis.
To differentiate intravascular and extravascular leukocytes, mice were injected intravenously with PE-or APC-conjugated anti-CD45 antibody 3 minutes before organ harvest.
Flow Cytometry
Single-cell suspensions were resuspended in FACS buffer containing HBSS with 0.3 mM EDTA and 0.2% FBS, and stained for 30 minutes with biotinylated anti-MerTK, followed by conjugated antibodies and conjugated streptavidin for a further 30 minutes. Table E1 in the online supplement outlines the complete list of antibodies used. For the analysis of BrdU incorporation, BrdU was administered by intraperitoneal injection of 1 mg per mouse daily for the time points indicated. Intracellular BrdU was detected according to the protocol from eBioscience (Waltham, MA). FACS data were acquired using the LSR II or LSR Fortessa (both BD Biosciences), and data were analyzed with FlowJo software (Ashland, Oregon). 49,6-diamidino-2-phenylindole was added immediately before acquisition to exclude dead cells.
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Frozen sections from CX 3 CR1 GFP/1 reporter mice were prepared by inflating the lungs with a mixture of 20% sucrose: 1% paraformaldehyde: 50% optimum cutting temperature reagent, after perfusion with 1% paraformaldehyde. Sections (10 mm) were stained with anti-MerTKor eF660-conjugated lymphatic vessel endothelial hyaluronan receptor 1 (Lyve-1) overnight, followed by Cy3-conjugated anti-goat antibody. Sections were imaged using Marianis (Denver, CO) or Zeiss (Denver, CO) fluorescent microscopes and analyzed with Slidebook (Denver, CO) and Image J (Bethesda, MD) software.
Phagocytosis Assays
For the in vivo assay, mice were anesthetized with Avertin, as described subsequently here, and intranasally instilled with a 50-ml suspension of Escherichia coli bioparticles (10 8 Figure  E2 in the online supplement). RNA was extracted from approximately 50,000 cells using the RNeasy Microkit (Qiagen, Hilden, Germany), as described in the manufacturer's protocols. pico chip). After library build, samples were run on a High Sensitivity DNA qubit assay (measuring 2 ul of library), diluted to roughly 1 ng/ul and run on a High Sensitivity DNA bioanalyzer chip (Santa Clara, CA). All samples were pooled together and run on Ion Proton P1 chips.
Reads of at least 30 nt length were mapped to the mm10 release of the mouse genome using STAR (version 2.5.1b; https://doi.org/10.1093/bioinformatics/ bts635) with splice site information from the Ensembl version 78 gene annotation (http://dec2014.archive.ensembl.org/). Read numbers and alignment quality metrics can be found in Figure E7 .
Reads mapping uniquely to each gene of the Ensembl 78 annotation were quantified with the featureCounts program from the subread software package (version 1.5.0p-1) (8) .
To identify genes with significant expression changes between macrophage types, an analysis of deviance was performed on the raw counts using the package, DESeq2 (version 1.8.1) (9) in R (version 3.2.0) (10) by comparing a model with the cell type and the replicate (pool of mice from which cells were extracted) as variables to a reduced model considering only the replicate using the likelihood ratio test. The replicate is incorporated to correct for any differences in individual mouse pools. For pairwise comparisons between macrophage types, we used a statistical model considering cell types and replicates from the entire data set and extracted contrasts between macrophage type pairs from the results of the Wald test.
Kyoto Encyclopedia of Genes and
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Mono genes AM genes Heat maps were generated using the GENE-E software (http://www. broadinstitute.org/cancer/software/ GENE-E/index.html) from the Broad Institute (Boston, MA). RNA-seq data were submitted to Gene Expression Omnibus (GEO): accession no. GSE94135.
Statistical Analysis
Statistical analysis was conducted using Prism software (GraphPad Software, Inc., San Diego, CA Figure 4 . Phagocytic capacity of IMs in vivo and ex vivo. In vivo, carboxylated latex beads, Escherichia coli, or zymosan bioparticles were delivered via the intranasal route. Particle uptake was assessed after 3 hours. Data are representative of two experiments with n = 3 per group. Ex vivo, Percoll-enriched pulmonary macrophages were given carboxylated beads or bioparticles in culture. Particle uptake was assessed after 1 hour. Data are representative of three experiments with n = 3 per group. ****P , 0.0005, ***P , 0.001, **P , 0.005, *P , 0.05.
Ex vivo
as the mean (6SEM). Statistical tests were performed using two-tailed Student's t test and ANOVA. A P value less than 0.05 was considered statistically significant.
Results
Identification and Transcriptome Analyses of Pulmonary IMs in the Naive Mouse
As a first step toward comprehensively identifying all pulmonary macrophages, flow cytometry analysis was performed on single cells isolated from naive mouse lungs. Previous work has demonstrated that the coexpression of MerTK and CD64 specifically identifies all macrophages within numerous organs, including the lung (12) . Therefore, to identify pulmonary macrophages, we first plotted all myeloid cells as MerTK versus CD64 ( Figure 1A and myeloid gating illustrated in Figure E1) Figure 1A ) (14), of which most were in the intravascular space ( Figure E1 ). Finally, we confirmed that all seven pulmonary mononuclear phagocytes identified (AMs, three IMs, two DCs, and a few Ly6C 1/int MHCII 1 monocytes) were extravascular and not intravascular by injecting fluorescently conjugated anti-CD45 into the circulation to label and exclude intravascular leukocytes from our analysis ( Figure E1) (15, 16 (Figure 2A) . First, we assessed whether IMs, like AMs, exhibit a macrophage signature (12) . Indeed, both IMs and AMs highly expressed bona fide macrophage genes, such as MerTK, Fcgr1 (CD64), Emr1 (F4/80), CD68, Lysozyme 2, Lamp1, and CD36, while lacking hallmark DC genes, such as CCR7, Dpp4 (CD26), and Zbtb46 ( Figure 2B ) (17) (18) (19) (20) (21) . However, there were also some major differences between AMs and IMs. Notably, unique cell surface molecules that are commonly used to identify AMs (22) (23) (24) were absent in all three IM groups. These included Marco, Siglec-F, and Csf2r (granulocyte/macrophage colony-stimulating factor receptor) ( Figure 2B ). In contrast, genes shown to report monocyte/macrophage linage (25) and repress self-renewal (26, 27) , such as Mafb and Maf, were expressed by IMs, but not AMs, which were previously identified as self-renewing (14) . Furthermore, IMs are thought to arise from postnatal monocytes (22, 28, 29) and monocyte-related genes, such as CD14, CD163, and Csfr1 (macrophage colony-stimulating factor [M-CSF] receptor) were highly expressed on IMs compared with AMs ( Figure 2B ) (30) . These data suggest that IMs may derive from circulating monocytes, but how often is unclear.
Next, we investigated whether the three IMs could be defined by a programing state (i.e., proinflammatory or reparative, classical or alternative, or "M1" versus "M2" like) (31, 32) . However, in the naive noninflamed lung, there was no clear distinction between the three IMs for these types of programing markers ( Figure 2C ). On the other hand, compared with the AMs, all three of the IMs expressed higher levels of inflammatory mediators and receptors, specifically complement components C1qa, C1qb, and C1qc ( Figures 2C and E3 ). In addition, several chemokine ligands, CCL7, CCL8, and CCL12, involved in reparative functions were expressed on IM1 and IM2 compared 
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with IM3 (33, 34) . In summary, gene expression analysis highlighted differences between AMs and IMs, along with a strong macrophage signature in general.
We next investigated the correlation of mRNA with protein expression (28, (35) (36) (37) . As illustrated in Figure 3 , all pulmonary macrophages expressed cell surface molecules F4/80, CD36, CD64, and CD206, although IM1 and IM2 expressed more CD206 than IM3. CD14 was solely expressed by IMs and not AMs ( Figure E4 ). Focusing on differences between the IMs, IM1 and IM2 expressed more Lyve-1 and CD169 compared with IM3. In contrast, IM3 expressed elevated levels of CCR2 and CD11c compared with IM1 and IM2 ( Figure 3A) . When the IMs were analyzed for the expression of CX 3 CR1, Csf1r, and Zbtb46 using reporter mice, all three IMs expressed high levels of CX 3 CR1 and Csf1r, and virtually no Zbtb46, a transcription factor expressed by endothelial cells, classical DCs, and their precursors (18, 19) ( Figure 3A) . Table 1 provides a summary of the gene and protein expression analyzed in the seven pulmonary mononuclear phagocytes identified in Figure 1A . Overall, the genes and proteins examined for pulmonary IMs closely align.
Because the IMs displayed a macrophage signature, one of the most functional characteristic of macrophages in general is their ability to engulf large exogenous beads, cells, and microbes. Therefore, we examined the IMs' phagocytic ability using carboxylated beads or microbial particles (E. coli bioparticles, Staphylococcus aureus bioparticles, or zymosan A bioparticles). First, uptake of particulates in vivo demonstrated that IM1 and IM2 appear to acquire microbial particulates more readily than IM3 (Figure 4) . However, when ex vivo experiments were performed to eliminate the constraint of the lung architecture and allow for equal access of particulates, there was no clear difference in the uptake of beads by AMs or IMs. On the other hand, zymosan bioparticles appeared to be more actively taken up by IM3 compared with IM1, IM2, and AMs ( Figure 4) . Overall, ex vivo data support a common macrophage function for the three IMs as highly phagocytic.
IMs Display a Slow Turnover Rate
Next, we investigated the proliferation and relative rate of IM turnover. To assess proliferation, wild-type mice were injected daily with BrdU to examine its incorporation into Ly6C 1 monocytes (thought to be IM precursor cells) and IMs. By Days 3 and 6, blood Ly6C 1 monocytes were highly labeled with BrdU, approximately 78 and 94% ( Figure E5) . However, by Day 6, the incorporation of BrdU in IMs was approximately 15-30%, similar to AMs, and substantially lower than Ly6C 1 monocytes (Figure E5 ), suggesting that Ly6C 1 monocytes are not rapidly, if at all, replenishing IMs in steady state.
To further distinguish the rate of IM turnover, we used two complementary approaches. The first approach was to create BM chimeras to monitor donor-derived replenishment of host AMs and IMs. To create BM chimeric mice, host CD45.1 mice were lethally irradiated with lead strips across their thorax. These strips protect the AMs and IMs from g radiation, while reconstituting CD45.1 host with donor CD45.2 BM cells (38) . At 5 weeks after irradiation, the frequency of donor-derived cells was assessed in IMs. IM3 demonstrated more donor cell replenishment compared with IM1 and IM2, with IM1 having the lowest level of replacement ( Figure 5A ). These data suggest that IM3 more readily replenishes from circulating precursor cells than IM1 and IM2. Parabiotic mice were used as an additional means of assessing the rate of IM turnover. In this model, congenic mice were surgically joined together to exchange circulatory blood. The relative rate of IM turnover was measured by the frequency of contribution from the partner mouse. At 15 weeks after surgical joining, IM3, compared with IM2 and IM1, contained more donorderived cells (Figure 5B ), supporting the concept that IM3 indeed replenishes its population from circulating precursor cells more readily than IM1 and IM2. Furthermore, we observed that the partner contribution to all IM subtypes was similar to AMs (analyzed by digestion and not bronchoalveolar lavage), and was significantly lower than that of interstitial pulmonary monocytes (14) , suggesting that IMs are long lived, and either slowly selfrenewing or sporadically replenished by circulating monocytes. Combined, these data demonstrate that the rate of IM turnover differs among the three IMs, with IM3 displaying the highest turnover rate.
IMs Are Located within the Bronchial Interstitium and Not the Alveolar Interstitium
Next, we investigated the location of pulmonary IMs using the CX 3 CR1
gfp/1 reporter mice and immunostaining for MerTK (Figures 6 and E6 ). The flow plot in Figure 6A illustrates how the expression of CX 3 CR1 distinguishes MertK Figure 6A ) (14) . Immunohistochemistry staining with MerTK, to identify macrophages, and Lyve-1, to identify lymphatic vessels, of lung sections demonstrated the presence of dual-positive MerTK (red) and CX 3 CR1 (green) IMs in the bronchial interstitium and bronchovascular bundles, but not in the pleura or alveoli ( Figures 6B, 6C , and E6). In contrast, AMs (MerTK
were clearly observed in the alveolar lumen ( Figures 6B and E6 ), but not within the bronchial tissues. Interestingly, we were able to observe both Lyve-1 1 and Lyve-1 2 IMs close to lymphatic vessels, also located within the bronchial interstitium ( Figure 6C ). These data demonstrate that, in a naive mouse, all three IMs are located within the bronchial interstitium and not alveolar interstitium.
IMs, Like DC Subtypes, Are Present in Other Organs besides the Lung
Unlike organ-specific macrophages (i.e., AMs, Langerhans cells, microglia, Kupffer cells, red-pulp macrophages, and peritoneal macrophages) that display their own unique transcriptional signature and function (12, 39) , IMs appear to have overlapping transcriptional profiles within multiple organs (28, (35) (36) (37) (Figures 7A  and E3 ). We hypothesize that, like DCs, IMs maintain their overall transcriptional profile and function regardless of the organ in which they reside. To support this hypothesis, we analyzed the top IM genes 17033  7232  8988  2237  1168  86  1706  2249  338  121  1162  928  805  965  37  47  836  648  608  205  1369   AM  AM  AM  IM1  IM1  IM1  IM2  IM2  IM2  IM3  IM3 previously reported in the skin and heart (referred to in the literature as P4 or R2 for IM1, P5 or R1 for IM2, and P3 or R8 for IM3) (28, (35) (36) (37) , and observed a similar gene expression profile for all three IMs reported in the lungs ( Figure 7A ). In addition, we extended our gating strategy using MertK, CD64, and CD11b to identify IMs in skin, heart, and gut. Like the lung, skin, heart, and gut contained three MertK 1 CD64 1 populations of IMs ( Figure 7B ). However, there were a few differences, such as that heart IMs did not express high levels CD11c and skin IMs expressed moderate to low levels of CX 3 CR1 ( Figure 7C ) (35, 37) . Overall, these findings suggest that three IMs, like the two main DC subsets, are present in other organs besides the lung (5, 39-41).
Discussion
In this study, we newly identified and characterized three pulmonary IMs. All three IMs displayed a strong transcriptional macrophage signature, which includes the expression of MerTK, CD64, CD68, F4/80, Mafb, and Lamp1, while lacking the classical DC chemokine receptor and transcription factor, CCR7 and Zbtb46. In addition, all three of the IM populations were large and highly phagocytic, supporting their designation as macrophages. Principal component analysis of the pulmonary mononuclear phagocytes transcriptomes illustrated that IMs were distinct from AMs and each other. Moreover, both transcriptome and protein analyses demonstrated that the three IMs differentially expressed proinflammatory cytokines, chemokine ligands, MHCII, CD11c, CD206, and Lyve-1, among other genes. Nonetheless, all three IMs expressed high levels of CX 3 CR1 and CD14. CX 3 CR1 and CD14 are required for the development of Ly6C 2 monocytes and monocytederived DCs (42, 43) . However, we observed that neither CX 3 CR1 nor CD14 was required for IM survival ( Figure E5 and data not shown). All in all, there were substantial similarities and differences between the IMs at both the transcriptional and protein level, although how these differences influence their functional roles in tissue will require further investigation.
Experiments with BrdU-treated mice, lung-shielded BM chimeras, and parabiotic mice demonstrated that IMs display a relatively slow turnover rate, even lower than that of AMs. Notably, IM3 was more readily replaced by circulating precursor cells than IM1 and IM2. At a glance, IM3 appears to resemble pulmonary monocytes containing high levels of CCR2, TNF-a, and IL-1b expression. However, more investigations are required to support a relationship between IM3 and nonlymphoid monocytes.
IMs are thought to derive from postnatal Ly6C 1 monocytes (28, 29 Finally, other studies have observed three IM populations in the skin, heart, and gut (28, (35) (36) (37) . The IMs described in these studies appear to share many of the same cell surface molecules and top transcribed genes as observed in the lung, particularly the expression of CD64, F4/80, MerTK, CD11b, CD206, CCR2, MHCII, C1q, Lyve-1, Mgl2, and Stab1. This led us to investigate whether our gating strategy would identify IMs in other organs. Indeed, we observed three IMs in the gut, skin, and heart with minor differences. Overall, these data lead us to hypothesize that the IM subtypes, like DC subtypes, most likely maintain a similar transcriptional profile and function regardless of the organ in which they reside, which is in striking contrast to tissue-specific macrophages (i.e., AMs, Langerhans cells, microglia, red-pulp macrophages, and peritoneal macrophages), of which the function and differentiation is dictated by the environment in which they reside in (5, 22, 23, 44) . n Author disclosures are available with the text of this article at www.atsjournals.org. ORIGINAL RESEARCH
